"We have unfinished business," he said. Here's what Gianakakos, who took heart-focused MyoKardia Inc. public in October 2015 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results